tiprankstipranks
Trending News
More News >
Torii Pharmaceutical Co Ltd (TRXPF)
OTHER OTC:TRXPF
US Market

Torii Pharmaceutical Co (TRXPF) Income Statement

Compare
4 Followers

Torii Pharmaceutical Co Income Statement

Last quarter (Q2 2024), Torii Pharmaceutical Co's total revenue was ¥14.86B, an increase of 6.98% from the same quarter last year. In Q2, Torii Pharmaceutical Co's net income was ¥1.34B. See Torii Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 54.64B¥ 48.89B¥ 46.99B¥ 41.70B¥ 43.00B
Gross Profit
¥ 24.79B¥ 23.38B¥ 24.34B¥ 21.74B¥ 22.30B
Operating Expenses
¥ 19.76B¥ 17.84B¥ 19.68B¥ 17.00B¥ 20.86B
Depreciation and Amortization
¥ 459.00M¥ 252.00M¥ 279.00M¥ 461.00M¥ 807.00M
EBITDA
¥ 5.83B¥ 5.97B¥ 5.05B¥ 4.69B¥ 38.51B
Operating Income
¥ 5.04B¥ 5.54B¥ 4.66B¥ 4.74B¥ 1.43B
Other Income/Expenses
¥ 557.00M¥ 182.00M¥ 111.00M¥ -513.00M¥ 36.27B
Pretax Income
¥ 5.59B¥ 5.72B¥ 4.77B¥ 4.22B¥ 37.70B
Net Income
¥ 4.12B¥ 3.94B¥ 3.37B¥ 3.50B¥ 27.37B
Per Share Metrics
Basic EPS
¥ 146.57¥ 140.38¥ 120.11¥ 124.47¥ 974.99
Diluted EPS
¥ 146.57¥ 140.38¥ 120.11¥ 124.46¥ 974.99
Weighted Average Shares Outstanding
28.10M 28.10M 28.09M 28.08M 28.07M
Weighted Average Shares Outstanding (Diluted)
28.10M 28.10M 28.09M 28.08M 28.07M
Currency in JPY

Torii Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis